Buy Allogene Therapeutics Inc Stock | ALLO Stock Price & Latest News | Public
ALLO

Allogene Therapeutics Inc

$0.00 (0.00%)Today

    About ALLO

    Allogene Therapeutics, Inc. operates as a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer. The firm develops a pipeline of off-the-shelf T cell prod...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.19
    -0.39
    -0.58
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.54

    Actual EPS
    Q3 2020

    Stats

    Market Cap$5,29B
    Volume36,49k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$55.00
    1 Year Low$17.43
    Open$38.09
    High$38.09
    Low$36.63

    Buy any stock with any amount of money.

    Download the App
    Download the app